Acute renal failure

被引:0
作者
Krych, M [1 ]
机构
[1] Univ Munich, Klinikum Grosshadern, Med Klin & Poliklin 3, D-81377 Munich, Germany
来源
INTERNIST | 2005年 / 46卷 / 01期
关键词
nephrotoxicity; acute renal failure; chemotherapy; tumor lysis syndrome; oncology;
D O I
10.1007/s00108-004-1316-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The acute renal failure is characterized by a rapid detoriation of the renal function. In addition to the usual prerenal, intrinsic and postrenal causes of an acute renal failure distinct causes have to be considered for oncological patients. Factors immanent to the malignant disease, e. g. paraneoplastic syndromes or retroperitoneal bulks can account for an acute renal failure. Paraproteins as produced by a multiple myeloma are other possible causes for renal dysfunction. For some anticancer drugs nephrotoxicity is a potential side effect, in particular for cisplatin, methotrexate, ifosfamide and melphalan. A hemolytic uremic syndrome may be induced by mitomycin and gemcitabine. Extensive surgery can be associated with rhabdonnyolysis and myoglobin-uria and results in renal impairment. Treatment of a chemosensitive neoplasia with a highly effective regimen may result in a tumor lysis syndrome with hyperuricemia, hyperkalemia, hyperphosphatemia and hypocalcemia.
引用
收藏
页码:30 / +
页数:8
相关论文
共 33 条
  • [1] Cisplatin nephrotoxicity
    Arany, I
    Safirstein, RL
    [J]. SEMINARS IN NEPHROLOGY, 2003, 23 (05) : 460 - 464
  • [2] Bishop MR, 2000, CLIN ONCOLOGY, P750
  • [3] Tumour lysis syndrome: new therapeutic strategies and classification
    Cairo, MS
    Bishop, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (01) : 3 - 11
  • [4] Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome
    Davidson, MB
    Thakkar, S
    Hix, JK
    Bhandarkar, ND
    Wong, A
    Schreiber, MJ
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 116 (08) : 546 - 554
  • [5] Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis
    Fadia, A
    Casserly, LF
    Sanchorawala, V
    Seldin, DC
    Wright, DG
    Skinner, M
    Dember, LM
    [J]. KIDNEY INTERNATIONAL, 2003, 63 (05) : 1868 - 1873
  • [6] A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis
    Goldman, SC
    Holcenberg, JS
    Finklestein, JZ
    Hutchinson, R
    Kreissman, S
    Johnson, FL
    Tou, C
    Harvey, E
    Morris, E
    Cairo, MS
    [J]. BLOOD, 2001, 97 (10) : 2998 - 3003
  • [7] JAKOB A, 1999, ONKOLOGIE, V5, P1066
  • [8] TUMOR LYSIS SYNDROME - PATHOGENESIS AND MANAGEMENT
    JONES, DP
    MAHMOUD, H
    CHESNEY, RW
    [J]. PEDIATRIC NEPHROLOGY, 1995, 9 (02) : 206 - 212
  • [9] Jörres A, 2001, INTERNIST, V42, P379, DOI 10.1007/s001080050765
  • [10] KAPLAN AA, 2001, THER APHER, V5, P165